All In Biotech

Drug Trial Radar · NCT06671470

A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects

Drug Interaction Study of YZJ-1139 Tablets With Ticagrelor Tablets

Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

27

Actual

Start

Aug 22, 2024

Primary completion

Sep 13, 2024

Study completion Oct 15, 2024

Sponsor

Sponsor type
Industry
First posted
Nov 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Primary Objective : To evaluate the effect of ticagrelor tablets on the pharmacokinetic characteristics of YZJ-1139 in healthy subjects; Secondary Objective: To evaluate the safety of ticagrelor tablets in combination with YZJ-1139 tablets in healthy subjects.

Conditions

  • Insomnia

Interventions

  • YZJ-1139 tabletsDrug

    Oral dose 20 mg

  • Ticagrelor TabletsDrug

    Oral dose 90 mg twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics of YZJ-1139(Cmax)Time frame: 48 hours
  2. Pharmacokinetics of YZJ-1139 (AUC0-∞)Time frame: 48 hours
  3. Pharmacokinetics of YZJ-1139 (AUC0-t)Time frame: 48 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shulan (Hangzhou) Hospital

    Huangzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.